Psychiatry, Insane Asylums, Mental Illness, ECT, Lobotomies, Freud & Jung | Lex Fridman Podcast #502
Lex Fridman
A crisis in modern psychiatry 0:00
Andrew Scull opens by describing psychiatry as a field trying to grapple with something enormously complicated, the human mind and its emotions, especially when a person's grip on reality breaks down through hallucinations, delusions, or the inability to relate to others. He argues there has been some limited progress over the last seventy five years, particularly with milder forms of distress, but far less progress with serious psychosis. The drugs and therapies available are symptomatic treatments, not cures, since there is no psychiatric equivalent of penicillin, and treatments often create new iatrogenic problems, meaning harms caused by the treatment itself, such as antipsychotics and antidepressants that work only partially and fail for a large share of patients.
How the DSM diagnostic system emerged 6:33
Scull traces psychiatry's diagnostic manual, the DSM, back to a crisis of reliability, where psychiatrists in different cities could not agree on what was wrong with the same patient. A fraudulent but influential 1973 study by David Rosenhan, called On Being Sane in Insane Places, sent fake patients into hospitals and found nearly all were diagnosed as schizophrenic, embarrassing the profession. In response, Robert Spitzer led the DSM III task force in 1980 to build a checklist system, so that a patient with six or more symptoms from a list would be labeled with a disorder like major depression. This symptom based approach gave the appearance of reliability, meaning consistent diagnosis across places, but not necessarily validity, meaning the diagnosis actually reflects an underlying reality, and it appealed to drug companies, insurers, and families seeking certainty.
The failed promise of brain based diagnosis 12:32
When DSM 5 was being planned in the early 2000s, the National Institute of Mental Health under Steven Hyman and later Thomas Insel pushed psychiatry toward genetics and neuroscience, betting that mental illness could be redefined by underlying brain pathology rather than symptoms. Insel later admitted, after the agency spent more than 20 billion dollars, that the lot of the mentally ill had not improved one bit. By around 2008 the DSM 5 effort abandoned the goal of a pathology based system and fell back on the same symptom checklist approach from 1980, prompting both Insel and Hyman to publicly call the finished manual unscientific and useless.
Brain versus mind is a false split 14:34
Scull pushes back on treating the brain and the mind, or biology and psychology, as separate boxes, calling that a category mistake, since the brain a person has today is shaped by environment and experience rather than fixed at birth. He cites Leon Eisenberg's remark that psychiatry moved from being brainless to being mindless, meaning it swung from ignoring biology under Freudian influence to now neglecting psychological and social factors amid enthusiasm for neuroscience. He notes that when antipsychotic drugs were discovered by accident in the early 1950s, nobody understood how they worked, and figuring that out helped reveal the brain's chemical signaling system, which helped launch the field of neuroscience, growing from a few hundred attendees at early conventions in the 1970s to tens of thousands today.
Drug companies and a stalled pipeline 26:02
Beyond diagnostic troubles, Scull points to pharmaceutical companies behaving unethically, hiding unfavorable data, manufacturing studies, and paying billions in damages, with Vioxx as one prominent five billion dollar example outside psychiatry. Neuroscience failed to produce new drug targets, so major companies shifted research money away from mental illness toward more profitable areas, leaving psychiatry with drugs that Steven Hyman said are no real advance on those stumbled upon in the 1950s.
Public policy and the abandoned mentally ill 27:07
Scull describes a policy failure layered on top of scientific limits, noting that a person with serious mental illness now dies fifteen to twenty five years earlier than average, a gap that keeps growing. He points to the visible results on city streets, people cycling between brief hospital stays, homelessness, and jail, and notes that the three largest providers of inpatient psychiatric care in the United States today are the Los Angeles County Jail, Cook County Jail in Chicago, and Rikers Island in New York, institutions never built to treat mental illness.
From asylums to a broken promise of community care 29:35
Asylums were originally built in a spirit of optimism, meant to rescue people from attics and jail cells and, through a therapeutic environment and structured work, to cure 60 to 80 percent of patients if they arrived early enough. That optimism curdled as asylums gained a bad reputation, and starting in the 1950s and accelerating in the late 1960s they were dismantled in favor of a promised community care system. Scull calls that promise a shell game without a pea, since no real substitute facilities were ever built for the seriously mentally ill, leaving the current situation he describes as a kind of dark age.
Kraepelin, Bleuler, and the shape of major categories 31:02
Scull outlines the historical roots of today's diagnostic categories, starting with German psychiatrist Emil Kraepelin, who worked through thousands of asylum records to separate dementia praecox, an illness with a one way downward course, from manic depressive illness, which could remit or cycle. Swiss psychiatrist Bleuler renamed the first category schizophrenia, though he spoke of the schizophrenias in the plural, sensing it lumped together a diverse group of conditions. Scull explains schizophrenia through its positive and negative symptoms, meaning added experiences like hearing voices or believing the television is speaking to you, alongside losses like flattened emotion and deteriorating language and social connection, and distinguishes this from depression, noting that the ancient Greek and Roman idea of melancholia, a severe depression with psychotic features, has since been folded into the much broader modern catchall of major depression.
Neurosis, Psychosis, and Milder Disorders 35:02
You hear how the nineteenth century separated neurosis, meaning something rooted in the brain, from psychosis, meaning something rooted in the mind or psyche, though the two categories blurred together by the century's end. Alongside dementia and psychosis sit milder but still genuinely painful conditions, including bipolar disorder, where people swing between exhausting mania and deep depression, along with phobias like fear of flying or school phobia, and hysteria, a diagnosis that fascinated Freud early on and that has been applied unevenly across races and especially against women.
The Asylum's Broken Promise 39:36
Early asylums began with genuine optimism and some real success, but discharge rates never reached the promised 70 or 80 percent, landing closer to 35 or 40 percent. Each year's leftover chronic patients piled onto the next, so asylums filled with people who might spend decades there and leave only in a coffin. When true cure rates were recalculated against the mixed population of new and old patients, they came out closer to 10 or 12 percent, leaving doctors needing an explanation for the gap between promise and reality.
Degeneration and Forced Sterilization 40:32
The explanation that emerged was degeneration theory, the idea that the mentally ill were evolutionary throwbacks with inferior biology who bred without self-control. This framing justified locking people away not for treatment but simply to keep them out of sight, and it led directly to sterilization laws. California was a pioneer in this practice and continued sterilizing patients until about 1960, and by then more than 60,000 sterilizations had been carried out across the United States, with California responsible for a disproportionate share.
From Sterilization to the Nazi T4 Program 43:00
One British psychiatrist compared unwanted patients to mongrel puppies that should be weighted in a sack and drowned, language that shows how dangerous this thinking had become. Democratic checks in North America, Britain, and Europe kept eugenicist calls for killing from gaining real support, but the Nazis seized on these same ideas once in power, labeling the mentally ill useless eaters. Hitler's T4 program, named after the street address where it was planned, made the mentally ill the first victims of what became the Final Solution, killing as many as a quarter million people and pioneering the gas chamber and its disguise as a shower, with German psychiatry largely collaborating in the process.
American Funding Behind German Research 46:33
The Rockefeller Foundation, at a time when government barely funded science or medicine, chose to invest heavily in psychiatry around 1930, partly because the field was scientifically underdeveloped and partly because several trustees had mental illness in their own families. Its money spread widely, including support for genetics research by Ernst Rudin in Germany, who absorbed the sterilization lessons from California and became a chief architect first of forced sterilization and later of the mass killing of psychiatric patients under the Nazis.
Walter Freeman and the Ice Pick Lobotomy 51:04
Lobotomy stands as the starkest example of a shaky science producing terrible results, beginning with Portuguese neurologist Egas Moniz, who won the Nobel Prize in 1949 despite only fourteen years of evidence. Walter Freeman, who wanted to become the Henry Ford of lobotomy, invented a faster method using an ice pick driven through the eye socket after a patient was knocked unconscious with electric shocks, and he toured state hospitals in a camper he called the Lobotomobile, sometimes performing 20 or 30 procedures in an afternoon and boasting he could teach any fool, even a psychiatrist, to do it in twenty minutes. The practice only faded as a younger generation confronted its worst outcomes, incontinent and mentally destroyed patients, and turned instead to new antipsychotic drugs, while the film of One Flew Over the Cuckoo's Nest fixed a lasting public image of both electroconvulsive therapy and lobotomy.
General Paralysis of the Insane and Syphilis 58:03
By the turn of the twentieth century, as many as 25 percent of asylum admissions suffered from general paralysis of the insane, a condition combining physical paralysis with bizarre delusions of being Napoleon or Jesus Christ. Researchers eventually discovered this was actually tertiary syphilis, a disease that could lie dormant for years like chicken pox before attacking the heart or nervous system, and this finding suggested for the first time that mental illness could have an infectious origin.
Malaria Fever Therapy and a Nobel Prize 1:01:00
Austrian doctor Wagner Jauregg, having failed with rat bite fever and typhoid vaccine, found that injecting patients with malarial blood from an infected soldier seemed to cure general paralysis of the insane, and the treatment spread internationally, with some hospitals even keeping colonies of malarial mosquitoes to bite restrained patients. Jauregg won the Nobel Prize in 1937 even though his cure claims were later admitted to be exaggerated, and the treatment only ended once penicillin arrived as a true cure for syphilis.
Germ Theory Transforms Medicine, Not Psychiatry 1:04:03
The discoveries of Louis Pasteur and Robert Koch established that bacteria caused many diseases, leading to vaccines and to the antiseptic and later aseptic surgical methods pioneered by Lister, who sprayed carbolic acid on wounds against the mockery of his colleagues. These breakthroughs, along with vaccines like the one for diphtheria, transformed general medicine's effectiveness and reputation, but this progress had not yet reached psychiatry until syphilis offered the first model of an infectious agent driving people's minds to disorder, a discovery that led Emil Kraepelin, who first distinguished schizophrenia from bipolar disorder, to wonder whether other mental illnesses might also have infectious roots.
Henry Cotton and Focal Sepsis 1:09:02
Henry Cotton trained under Adolf Meyer and became head of the New Jersey State Mental Hospital at Trenton, determined to modernize psychiatry and remove chains and straitjackets. When patients still failed to improve, he adopted the theory of focal sepsis, the idea that low grade infections release toxins into the blood and poison the brain. Without antibiotics available, his solution was surgical bacteriology, starting with pulling teeth, then removing tonsils, and eventually taking out stomachs, spleens, and colons. He claimed an eighty percent cure rate and drew wealthy patients from across America, even giving a prestigious lecture series at Princeton published by Oxford and Princeton University Press and praised by the New York Times, despite the fact that forty five percent of patients who underwent the abdominal surgery died within a year. Cotton once compared stomachs to disposable cement mixers. He died in 1933, but his successors kept pulling teeth and tonsils until 1960, and the dentist who performed hundreds of thousands of extractions still believed Cotton deserved a Nobel Prize.
Why the Fraud Persisted 1:13:02
Asked why intelligent doctors and the public accepted such claims, the guest points to the power of placebo effect layered on top of dramatic medical procedures. Patients wanted to believe painful, invasive treatments performed by authoritative figures in white coats would help them, and doctors wanted to see their interventions succeed, making self-deception easy on both sides. This dynamic, distinguishing real therapeutic effect from placebo, remains a persistent challenge in psychiatry today.
Insulin's Real Triumph 1:15:03
As a contrast, the discovery of insulin in the 1920s is described as a genuine medical triumph, transforming type one diabetes from a death sentence into a manageable condition, even though it wasn't a cure. This success set the stage for a much stranger application: inducing insulin comas as a psychiatric treatment.
Insulin Coma Therapy 1:16:00
A doctor named Sakel, who had used mild comas to ease drug withdrawal, began inducing hours or days long comas in schizophrenic patients, reviving them with glucose. Seizures during the comas were seen as a good sign, and Sakel claimed an eighty percent cure rate, bringing the treatment to New York's Harlem Valley Mental Hospital in the 1930s and building a lucrative practice. The therapy demanded intensive nursing since patients could die or slip into permanent coma, and evidence suggested it killed brain cells, which Sakel simply reframed as killing the diseased cells. Not tested in a randomized controlled trial until the 1950s, it failed and was abandoned. John Nash, later portrayed in A Beautiful Mind, received insulin comas at the very same Trenton hospital Cotton had run, and narrowly avoided being lobotomized; the treatment carried a one to five percent mortality rate and caused brain damage and obesity.
Chasing Artificial Seizures 1:20:03
Based on the mistaken belief that epilepsy and schizophrenia could not coexist, another psychiatrist tried to induce artificial seizures to drive out schizophrenia, first with camphor, which caused abscesses, then with a drug called Cardiazol or Metrazol. This produced violent grand mal seizures capable of fracturing spines and hips, and patients reported feeling as though they were about to die in the minutes before convulsing.
Electroshock Is Discovered 1:22:35
Seeking something less distressing, Italian psychiatrists Cerletti and Bini experimented with electricity on dogs, initially killing them by passing current from head to anus. After observing pigs stunned by head electrodes at a Roman slaughterhouse, they adapted the method, found it didn't kill the dogs, and tested it on a homeless man picked up at Rome's train station. After a low dose did nothing, they increased the current despite his protest, producing a seizure with the same fracture risks, followed by his contact with reality upon waking. The technique spread quickly across Europe and America as an easy, cheap intervention.
ECT's Complicated Legacy 1:25:02
Electroconvulsive therapy proved ineffective for schizophrenia but useful for suicidal depression, and unmodified ECT dominated treatment into the 1950s and 60s, causing fractures and memory loss, and often functioning more as behavioral control in asylums than genuine therapy. The introduction of muscle relaxants eliminated fractures but required anesthesiologists and breathing support, and the treatment remains controversial, often needing repetition as maintenance therapy, with real concerns about memory loss and brain damage. In places like California, involuntary patients now cannot be given ECT without consent, reflecting how contested it remains even for treatment resistant depression, the label given to patients whom drugs fail to help.
Distrust and the Cost of Broken Trust 1:30:36
Every psychiatric treatment draws both fierce defenders and fierce opponents, from those helped by drugs to Scientologists who call psychiatry an industry of death. This mirrors the broader collapse of trust in vaccination and science generally, worsened by pandemic-era disruptions that aborted clinical trials, cut scientist training pipelines for years, and made an entire generation of research invisible through lost counterfactuals. Genetics research, meanwhile, has failed to find clean genetic markers for diseases like schizophrenia, with genome-wide studies of three hundred variations explaining only about ten percent of the condition, and evidence now suggests disorders like schizophrenia, bipolar disorder, and autism overlap genetically rather than existing as distinct categories, a finding that could further unsettle public trust if psychiatry eventually abandons these diagnostic labels altogether.
Hype, Journalism, and Caution 1:38:06
Current excitement over ketamine and psychedelics as depression cures echoes the same overblown eighty percent cure rhetoric seen with Cotton and Sakel, and the guest urges skepticism toward science journalism's tendency to chase breakthroughs, noting journals like Science and Nature also favor splashy positive findings over the negative results that guard against error. Progress usually arrives in small steps, with occasional genuine leaps like penicillin, and having many scientists working independently across different sites serves as a check on premature or unfounded claims, even though maverick researchers pursuing unconventional ideas often struggle to get funding or a hearing.
Postwar Mental Hospitals and Veterans 1:43:01
Mental hospitals in America took much of their modern shape after the Second World War, when psychiatric casualties among troops ran two to three times higher than in the First World War, when the condition was called shell shock. This surge led the Veterans Administration to fund training for psychiatrists and psychologists and to build a large mental hospital system, which became a major force in the field's postwar development.
Cuckoo's Nest, Book Versus Film 1:45:00
The novel One Flew Over the Cuckoo's Nest and its 1975 film share the same basic story of McMurphy, played by Jack Nicholson, clashing with Nurse Ratched, played by Louise Fletcher, but the book is stranger and more political, centered on Chief Bromden's inner world, while the film is more naturalistic and turns McMurphy into a straightforward hero. Among students shown many classic films about madness, this one was almost always the film everyone had already seen, unlike something like Hitchcock's Spellbound.
Other Notable Films About Madness 1:46:01
Alongside Cuckoo's Nest, I Never Promised You a Rose Garden offered a more sympathetic picture of Freudian psychiatry, loosely based on Frieda Fromm-Reichmann, who treated schizophrenia with psychotherapy rather than drugs at Chestnut Lodge in Maryland. Pat Barker's World War I trilogy became the film Regeneration, dealing with shell shock, and novelist Patrick McGrath, who grew up on the grounds of Broadmoor and was babysat by patients there, wrote the macabre novel Asylum. A Hollywood producer once told the guest his own book Madhouse had a great first and second act but no happy third act, since the real story ended grimly.
Hospital Life and Staff Abuse 1:50:02
Cuckoo's Nest captured real features of mental hospitals: the poverty of the physical environment, staff putting patients down or mocking them, and the sheer boredom of institutional life. Abuse was almost inevitable because the people with the most contact with patients were the lowest paid, least respected ward attendants, while doctors were spread so thin across large state hospitals that patients rarely saw a physician at all. The film's chief psychiatrist was played by the actual head of Oregon State Mental Hospital, and though the depiction of ECT as a tool of discipline was exaggerated, it was true that ECT was used far more for control in the fifties and sixties than for therapy.
Women and Psychiatric Treatments 1:51:33
Across nearly every harsh psychiatric treatment discussed, women bore the brunt: about 70 percent of Henry Cotton's patients were female, and lobotomy records repeatedly show 60 to 70 percent female patients. ECT skews heavily female too, partly because depression is diagnosed more often in women, while men more often receive diagnoses like personality disorders or ADHD. The film's portrayal is credited with reducing interest in ECT for decades and still creates hesitation about the treatment today.
ECT's Complicated Legacy 1:53:01
ECT has a genuinely dark history, including CIA-funded experiments by Ewen Cameron in Canada, who gave patients multiple ECTs a day, reducing some to being unable to walk, talk, feed themselves, or control their bladder before claiming to rebuild them. Yet controlled trials now show real evidence it works for severe, treatment-resistant depression, sometimes described by patients as lifesaving. What unsettles people is that it remains a purely empirical treatment with no understood mechanism, unlike surgically removing a cancer or treating high blood pressure with a daily pill, which makes it harder to trust even when it works.
Writing Desperate Remedies 1:56:00
The idea for the book Desperate Remedies began in 1981 during a Guggenheim Fellowship in London, but it took forty years to write, allowing the author to capture major developments in psychiatry after 1980 that an earlier version would have missed. Working on multiple projects at once over decades let ideas percolate, and psychiatry kept his interest because it involves immense human suffering found in every society studied, from ancient Greece to ancient China, and because its complexity leaves enormous room for genuine intellectual puzzles that remain far from solved.
Religious Roots of Talk Therapy 2:02:00
Before psychoanalysis, nineteenth-century America produced new religious movements that addressed milder mental distress outside asylums. The Seventh Day Adventists spawned a sanitarium later run by the Kellogg family, attracting figures like Abraham Lincoln's widow, Tarzan's creator, and Henry Ford, blending mental recovery with beliefs about diet and digestion. Mary Baker Eddy's Christian Science taught that disease could be prayed away through sufficient faith, drawing a large following, mostly women, and sharp critics like Mark Twain, while Boston's Emmanuel Movement briefly tried blending medicine and religion before doctors withdrew from it.
Neurologists, the Rest Cure, and Nerves 2:06:30
After the Civil War, neurology emerged in America from studying brain and nerve injuries, and clashed with asylum-based psychiatry over who owned the study of insanity. Neurologists began treating outpatients with milder disorders using static electricity and tonics, and most notably the rest cure devised by Silas Weir Mitchell, which prescribed total bedrest, heavy eating, and no intellectual stimulation, mainly for women, and which Virginia Woolf said nearly drove her mad. Mitchell's bestselling books Wear and Tear and Fat and Blood blamed modern life's pace, like the telegraph and railway, for overtaxing the nervous system, a complaint strikingly similar to today's worries about social media and constant connectivity.
Freud and Jung Arrive in America 2:09:02
In 1909 Sigmund Freud traveled with two colleagues, including Carl Jung, to Clark University in Massachusetts, an event often remembered as a Freud conference though he was actually a minor figure among some thirty speakers, including two Nobel laureates and anthropologist Franz Boas. Freud delivered his five lectures in German, since the American audience had learned it to read medical literature, and William James attended but was unimpressed, while mainstream American psychiatry largely dismissed Freud's talk therapy as absurd for what they saw as a biological condition. One convert made there was Harvard neurology professor James Jackson Putnam, and Jung, who had persuaded a reluctant Freud to make the trip despite his contempt for America, would later attract the wealthiest patients himself, a factor in their eventual, bitter split in 1913.
Origins of Psychoanalysis and Anna O 2:15:32
Freud trained as a neurologist and studied hysteria under Jean-Martin Charcot in Paris, translating his work into German to build his own career, though Freud's Viennese colleagues thought little of Charcot or of Freud's borrowed ideas. Back in Vienna, Freud partnered with the more established Josef Breuer, who referred patients to him and had treated a woman known as Anna O, real name Bertha von Pappenheim, whose case became the founding example for psychoanalysis.
Anna O. and the birth of psychoanalysis 2:17:31
Anna O. was Breuer's patient, not Freud's, and her case became foundational to psychoanalysis. She had nursed her dying father and afterward developed physical symptoms and depression, which Breuer and Freud explained through the idea of repressed memories and trauma. This became the basis of their book Studies in Hysteria, which laid out case vignettes suggesting that hidden past experiences, sometimes real traumas like childhood sexual assault, get pushed out of awareness yet resurface in distorted symptoms. Freud developed the concept of resistance, the idea that people unconsciously fight against retrieving these memories, and that only slow, painful work could bring them into consciousness and transform the personality.
Freud's expanding theory of mind 2:20:31
Freud increasingly emphasized childhood experience, arguing that early traumas and socialization leave deep, lasting marks on the psyche, a view even some biologically minded psychiatrists now accept. He built out an elaborate theory involving psychosexual stages, libido, and repressed sexuality, ideas that eventually split him from Carl Jung, who downplayed the sexual dimension. Trained as a neurologist, Freud first tried to root psychology in biology through an essay called Project for a Scientific Psychology, but abandoned that path. He then wrote The Interpretation of Dreams, treating dreams as disguised expressions of hidden material, and became interested in slips of the tongue as further clues to what people were suppressing. This resulted in his structural model of personality: the id, driven by pleasure and basic drives, the ego, which rationally mediates between the id and reality, and the superego, the internalized moral conscience.
Jung's wealthy patients 2:23:30
Jung attracted extraordinarily rich patients, including an heir to the International Harvester fortune, a US senator who later took his own life after losing reelection. He also treated Edith Rockefeller, who married into the McCormick family and suffered from severe agoraphobia, once having her chauffeur follow her train in a Rolls Royce in case she needed to flee at a stop. She became a Jungian analyst and funded Jung generously, and Jung later drew support from Paul and Mary Mellon, whose foundation subsidized publication of his works through Princeton University Press. Freud, by contrast, never attracted patients of quite that wealth, though he did gain some rich American followers.
Freud's cultural rise and shell shock 2:26:00
Freud's ideas gained real traction in America in the 1920s, especially among the intellectual and artistic class, while most clinical psychiatrists, working mostly in asylums with psychotic patients, wanted nothing to do with talk therapy. World War I's mass psychological breakdowns, initially labeled shell shock and blamed on physical damage from exploding shells, gradually came to be understood as psychological trauma, giving Freud's ideas new credibility. Novelists, painters, and playwrights embraced psychoanalysis because, as Freud himself admitted, his case histories read like short stories rather than hard science, and psychoanalysis was fundamentally about recovering and reconstructing personal narratives. Still, by 1930 there were only about three hundred psychoanalysts in North America, nowhere near enough to treat the hundreds of thousands of patients in hospitals.
Emigration and institutional growth 2:30:00
Hitler's persecution of Jews, including psychoanalysts, forced many to flee, with Freud himself escaping to London after Princess Bonaparte bribed the Nazis, even as he suffered from jaw cancer. His daughter Anna became a central figure in British psychoanalysis, while other analysts settled in America, roughly doubling the number of practitioners by 1940. Psychoanalytic training became organized through independent institutes rather than universities, which gave the field tight control early on but became a structural weakness later, since it resisted integration when universities became the dominant centers of knowledge after the war. The process of psychoanalysis itself involved intensive commitment, five fifty-minute sessions a week, evolving from Freud's early experiments with hypnosis, learned from Charcot in Paris, toward free association after his break with Breuer.
Pressure to prove psychoanalysis works 2:34:01
After World War II, as psychoanalysis expanded in America with Rockefeller Foundation support, funders like Alan Gregg and Robert Morison repeatedly pressed analysts to prove their methods worked, but analysts resisted, insisting the process of reconstructing entire personalities could not be reduced to simple measures. Meanwhile, wartime demands exposed deep problems. American psychiatrists had screened out 1.75 million recruits before the war to prevent breakdowns, but breakdowns still occurred, with up to 25 percent of soldiers in combat conditions succumbing to what had once been called shell shock, unlike the Nazis, who simply shot affected soldiers. William Menninger, heading Army psychiatry, concluded trauma-based, psychotherapeutic treatment was best, spreading a watered-down Freudian approach among rapidly trained wartime psychiatrists.
Psychologists build a rival profession 2:39:31
Because there were not enough psychiatrists, psychologists were drafted into treatment roles during the war and discovered they were good at it, sparking a postwar movement to formalize clinical psychology. With VA and later National Institute of Mental Health funding, psychologists built training programs combining scientific research methods with clinical practice, which made them far more successful than psychoanalysts at securing federal grants. Unlike psychoanalysts, who saw treating symptoms alone as pointless, comparing it to a game of whack-a-mole that ignores deeper personality conflicts, clinical psychologists focused directly on symptoms through techniques that became cognitive behavioral therapy and later interpersonal therapy. These methods were reproducible, testable, and far less time-intensive than the five-sessions-a-week psychoanalytic model.
CBT's real but limited effectiveness 2:45:02
Key figures in this shift included Albert Bandura, Albert Ellis, and Aaron Beck, a former psychoanalyst who became disillusioned and pushed psychiatry toward more reliable diagnosis, influencing the later DSM-III, while also helping build cognitive behavioral therapy focused on repairing damaging patterns and relationships. Americans, used to paying for medical care rather than relying on socialized medicine, proved willing to pay for this kind of practical therapy aimed at everyday distress. Yet the evidence is mixed: Cochrane Reviews rate CBT's evidence as only low to medium confidence, and it performs poorly for conditions like schizophrenia, though it appears to work better than drugs, with fewer side effects, for milder depression, a conclusion backed by Britain's NICE health guidance. It works well for some people who have fallen into poor habitual ways of responding to the world, but it is not a cure-all.
Accidental rise of psychiatric drugs 2:50:36
Before psychopharmacology, drugs used in mental hospitals mainly served to sedate and control agitated patients, using opiates, hypnotics, and occasionally marijuana or alcohol, not to treat underlying illness. The modern drug industry had emerged largely in Germany, refining substances like coal tar into medicines such as aspirin, and World War II accelerated pharmaceutical development dramatically, most notably through the discovery of penicillin. Alexander Fleming observed penicillin's bacteria-killing effect in his lab and later shared a Nobel Prize for it, but it was Howard Florey and his Oxford team who actually developed its therapeutic use, with Florey personally carrying some of the drug in his jacket.
The Accidental Discovery of Chlorpromazine 2:53:01
The story of antipsychotic drugs begins with penicillin's mass production in America during the war, which fattened drug companies and pushed them toward finding new chemical treatments. A French company, Rhône-Poulenc, revisited a chemical synthesized in Germany back in the 1880s, an antihistamine called chlorpromazine. With almost no regulatory controls at the time, researchers handed the drug out to see what it might do, testing it as an antiemetic, an eczema treatment, and eventually as an anesthetic potentiator. A French Navy lieutenant, Henri Laborit, gave it to surgery patients and noticed it made them strangely unbothered by their anxiety, describing it to a relative working in a Paris mental hospital as producing something like a "chemical lobotomy." That comment led psychiatrists Delay and Deniker at Saint-Anne's hospital to try it on psychiatric patients, where larger doses calmed agitation and stopped destructive behavior, earning the drug its early label as a "major tranquilizer," known as Largactil in Europe and Thorazine in America.
Chlorpromazine Crosses the Atlantic 2:57:33
The drug reached North America through Quebec psychiatrist Heinz Lehmann, since American physicians distrusted European medicine and two drug companies initially turned down the rights. SmithKline & French eventually bought them, and within two years two million people were taking the drug, largely because the company put its best salesmen on the job and lobbied state legislatures with footage of agitated patients turning calm. This success spawned copycat drugs, followed in 1955 by so-called minor tranquilizers like Miltown, promoted heavily by television star Milton Berle. In the early 1960s these major tranquilizers were rebranded as "antipsychotics," a name suggesting they attacked the underlying illness rather than just calming patients.
Positive Symptoms Versus Negative Symptoms 3:00:31
Antipsychotics do reduce what psychiatrists call the positive symptoms of schizophrenia, meaning hallucinations, delusions, and agitation, though not for every patient. They do far less for the negative symptoms, things like apathy, loss of ability to interact with others, poverty of language, and lack of initiative, symptoms that are just as devastating despite the confusing label. A significant portion of patients simply do not respond to these drugs at all, much as many depressed patients don't respond to antidepressants.
The Hidden Cost of Side Effects 3:03:00
For two decades the serious side effects of antipsychotics were largely ignored, with some in the field even arguing the side effects were proof the drug was working. These included incurable restlessness, Parkinson's-like symptoms, and the particularly nasty tardive dyskinesia, a late-developing condition causing jerky, uncontrolled movements, protruding tongues, strange noises, and staggering. A 1975 Science paper by psychiatrist George Crane forced the profession to confront this harm, and by the 1980s the American Psychiatric Association was seriously worried, though no fix existed until clozapine was revived, a drug that avoided tardive dyskinesia but could destroy white blood cells, requiring weekly blood monitoring.
Second Generation Drugs and the CATIE Study 3:07:03
Clozapine's revival opened the door to a new class called second generation antipsychotics, including Risperdal and Zyprexa, chemically distinct from each other but marketed and perceived as a group. Because drug companies funded and controlled most trial data, and FDA approval required only two successful trials regardless of how many failed, a government-funded 2005 study called CATIE offered a rare independent look. It found the newer, far more expensive drugs were no more effective than the old, cheap first-generation drug, and that between 67 and 82 percent of patients dropped out of the trial due to ineffectiveness or intolerable side effects, most notably severe weight gain leading to diabetes and heart trouble.
No Way to Predict Who Responds 3:11:30
Every drug carries a cost-benefit tradeoff, and there is currently no biological marker to predict which patients will respond well and which will suffer the worst side effects. Some researchers hope psychiatric genetics might eventually identify responders in advance, but this remains only a hope, not a working tool. Side effects on personality and mental richness are especially hard to describe or measure, and some patients drop out of treatment because they'd rather tolerate hallucinations than lose the depth of their inner life.
SSRIs and the Marketing of Depression 3:13:30
Antidepressants followed a similarly accidental path, discovered when tuberculosis patients given experimental drugs in the 1950s suddenly became happy and energetic. Drug companies initially saw depression as a small market, but that changed as depression became, in the source's words, "the common cold of psychiatry." Disputes arose, such as whether grief and bereavement should count as depression in DSM-5, illustrating a repeated pattern called "diagnostic creep," a term coined by Nick Haslam, where the boundaries of a diagnosis expand outward from a clear core into a wider, blurrier "penumbra." DSM-IV editor Allen Frances has argued the surge in autism diagnoses reflects loosened criteria more than an actual rise in cases, a claim many parents understandably resist given how much social and educational support hinges on the diagnosis.
Prozac and the Serotonin Story 3:20:00
Older antidepressants, MAOIs and tricyclics, carried real dangers, including fatal overdose risk and deadly interactions with foods like cheese and cured meats. Prozac and the SSRIs that followed avoided those risks and were marketed, notably by public advocate Tipper Gore, on the idea that depression stemmed from too little serotonin, which the pills would correct. In controlled studies these drugs beat placebo by a statistically significant margin, but often not by a clinically meaningful one, meaning a one or two point shift on a sixty point rating scale that barely changes quality of life. Many patients describe SSRIs as numbing, flattening emotional highs and lows and frequently destroying libido, sometimes permanently, while withdrawal can bring depression worse than before and leave people feeling trapped on the drugs indefinitely.
Who Benefits and Who Doesn't 3:24:31
A recent Lancet study captured the pattern across both antipsychotics and antidepressants: one group of patients responds well with bearable side effects, another group of over 40 percent among depressed patients sees no benefit at all while still carrying risk, and a middle group gets some improvement alongside real side effects. Neither patient nor doctor can know in advance which group someone will fall into. Another shift from the drug revolution is that prescribing has moved beyond psychiatrists themselves, with primary care doctors now dispensing most antidepressants.
What Should Someone Actually Do 3:26:30
For someone suffering from psychosis or depression, trying medication is often necessary because the suffering is so intense, but it requires a clinician monitoring closely and awareness of the tradeoffs involved. More broadly, psychiatric research has poured its resources into drugs, neuroscience, and genetics while neglecting the psychosocial dimensions of mental illness, and building real career paths for psychiatrists in that neglected area would improve patients' and families' lives more immediately.
Funding gaps in psychiatric research 3:27:35
Academic psychiatrists depend on grant money, and there is little funding available to study practical problems like easing homelessness or helping families cope with a hallucinating relative. Andrew Scull suggests that redirecting research toward these everyday coping challenges would genuinely help.
Talk therapy and the future of AI 3:28:00
Psychoanalysis has become a niche product mainly available to the wealthy, though some who use it say it helps. Lex raises the possibility that advancing artificial intelligence, capable of holding deep personal conversations, could take on a role resembling psychoanalysis, and Scull notes that COVID already pushed people toward distance therapy when in-person sessions were unavailable, suggesting parts of this could indeed become mechanized.
Policy, drugs, and social support 3:30:33
Scull is pessimistic about fixing public policy on serious mental illness because real solutions would cost significant money, and there is little incentive since curing patients doesn't turn them into taxpayers in the way policymakers respond to. He hopes for a pharmaceutical breakthrough, since he believes major mental illnesses have a real biological component, but laments that big drug companies have abandoned research in this area. He stresses that loneliness and isolation harm mental health, so building social support and a sense of agency matters alongside drug and talk therapy research.
Hope for psychiatry's future 3:32:02
Scull points to many well-meaning people in psychiatry who witness suffering firsthand and have already moved the field forward, despite its dark history. He calls for a shift away from a technocratic mindset that leans only on medication, toward a system that genuinely attends to and eases suffering, and he urges against cynicism, insisting progress remains possible and hopefully will accelerate.
Closing message and farewell 3:35:03
Lex closes by addressing listeners who are currently suffering, offering encouragement and solidarity, then thanks Andrew Scull for the conversation and his historical work on psychiatry. Scull thanks Lex in turn for his preparation, and Lex ends the episode with a quote from Friedrich Nietzsche about finding meaning in suffering.
AI-generated summary. It can be wrong or incomplete - check anything that matters against the original.
